Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Reference Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Share this article (PRNewsfoto/Eurofins U.S. Clinical Diagnost) FRAMINGHAM, Mass., Dec. 16, 2020 /PRNewswire/ -- Eurofins announces that its FDA-authorized At-Home COVID-19 Nasal PCR Test is now being offered in all 50 states. Previously, the At-Home test was not available for use in New York, New Jersey, Rhode Island and Maryland. The Emergency Use Authorization ("EUA") authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home. Results are provided via email link within 24 hours of sample receipt. Available ...